Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized Double Blind Placebo Controlled Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa

Trial Profile

Randomized Double Blind Placebo Controlled Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Nov 2018

At a glance

  • Drugs Botulinum toxin B (Primary)
  • Indications Hidradenitis suppurativa
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 24 Oct 2018 Status changed from active, no longer recruiting to completed.
    • 06 Nov 2017 Planned End Date changed from 23 Jun 2018 to 23 Sep 2018.
    • 06 Nov 2017 Planned primary completion date changed from 23 Nov 2017 to 23 Mar 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top